December 2015

New Product - Latuda

Latuda (lurasidone hydrochloride) is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. It has antagonist activity on the dopamine 2 (D₂) and serotonin (5HT_2A) receptors. Latuda is indicated for the treatment of adults with schizophrenia. It is contraindicated with strong CYP3A4 inhibitors (e.g. ketoconazole, clarithromycin, ritonavir, and voriconazole) and strong CYP3A4 inducers (e.g. rifampicin, St. John’s wort, phenytoin, and carbamazepine). Latuda is available as 40 mg and 80 mg tablets in packs of 30’s.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au